OBRIEN MORGAN E 4
4 · Anterix Inc. · Filed Mar 22, 2022
Insider Transaction Report
Form 4
Anterix Inc.ATEX
OBRIEN MORGAN E
DirectorVice Chairman of the Board
Transactions
- Exercise/Conversion
Common Stock
2022-03-15$25.00/sh+25,000$625,000→ 61,287 total - Sale
Common Stock
2022-03-15$55.37/sh−6,595$365,132→ 54,692 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-15−25,000→ 115,000 totalExercise: $25.00Exp: 2025-01-29→ Common Stock (25,000 underlying) - Sale
Common Stock
2022-03-15$56.25/sh−18,405$1,035,336→ 36,287 total
Footnotes (4)
- [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $54.76 to $55.75. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.99 to $56.575. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]The option shares are fully vested.